FInCo Seminar: Drug repurposing in oncology — promise and reality

Sartar Therapeutics: Drug repurposing in oncology — promise and reality

Speaker
Harri Sihto, PhD, Adj. Prof.
Co-Founder and Chairman of the Board, Sartar Therapeutics

Harri Sihto will discuss the practical realities of building a biotech company in today’s challenging funding environment. Topics will include:

• funding challenges and solutions
• investor expectations
• building the company and team step by step
• major product pivots during development
• practical challenges of drug repurposing in oncology
• the importance of collaborations and support networks in advancing a company with limited funding

The seminar will focus on practical lessons from the Sartar Therapeutics journey rather than the scientific details behind the product.

Registration
Please register, especially if you plan to attend in person:
https://elomake.helsinki.fi/lomakkeet/138531/lomake.html

The same form can also be used to submit questions to the speaker in advance.

Online participation
Registered participants will receive the Zoom link by email shortly before the seminar.

The seminar will be recorded and shared afterwards.